BOSTON, Feb 1 (Reuters) - Swiss drugmaker Roche Holding AG has offered to pay a royalty to Amgen Inc in order to be able to sell its anemia drug Mircera in the United States, according to court ...

BOSTON, Sept 5 (Reuters) - Amgen Inc and Roche Holding AG laid out opening arguments on Wednesday in a trial that will determine whether Roche can sell its anemia drug Mircera in the United States to ...

Roche Holding AG was barred by an appeals court on Friday from selling the anemia drug Mircera in the United States, after a judge found that the company infringes Amgen Inc.’s patents. The U.S. Court ...

Amgen Inc. said late Tuesday that a U.S. district court issued a final injunction that bars Swiss drug maker Roche Group from selling its anemia drug Mircera in the United States until 2014. The ...

Credit: Getty Images. Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. Vadadustat was found to be noninferior to a long-acting erythropoiesis-stimulating agent (ESA) for ...